Working... Menu
Trial record 3 of 5 for:    "Wilson Disease" | "Micronutrients"

Efficacy and Safety Study of Zinc Acetate to Treat Wilson's Disease in Japan.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00212368
Recruitment Status : Completed
First Posted : September 21, 2005
Last Update Posted : September 10, 2010
Information provided by:

Brief Summary:
The purpose of this study is to determine whether Zinc Acetate is effective and safe in the treatment of Wilson's disease among Japanese.

Condition or disease Intervention/treatment Phase
Wison's Disease Drug: Zinc acetate Phase 3

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Phase3,Open-label,Clinical Trial of Zinc Acetate for Treatment of Wilson's Disease in Japan.
Study Start Date : October 2004
Actual Primary Completion Date : August 2005
Actual Study Completion Date : December 2005

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   1 Year and older   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Wilson's disease(adult,infant,pregnant woman)

Exclusion Criteria:

  • acute hepatitis
  • malignant tumor

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00212368

Sponsors and Collaborators
Layout table for investigator information
Study Director: Koudou Ishii, M.D. National MINAMIYOKOHAMA Hospital

Layout table for additonal information Identifier: NCT00212368     History of Changes
Other Study ID Numbers: NPC-02-1
First Posted: September 21, 2005    Key Record Dates
Last Update Posted: September 10, 2010
Last Verified: September 2010

Additional relevant MeSH terms:
Layout table for MeSH terms
Hepatolenticular Degeneration
Trace Elements
Liver Diseases
Digestive System Diseases
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Brain Diseases, Metabolic, Inborn
Brain Diseases, Metabolic
Movement Disorders
Heredodegenerative Disorders, Nervous System
Neurodegenerative Diseases
Genetic Diseases, Inborn
Metabolism, Inborn Errors
Metal Metabolism, Inborn Errors
Metabolic Diseases
Growth Substances
Physiological Effects of Drugs